ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clinical Effectiveness of Olaparib in BRCAm, HER2- mBC by ER Expression Level
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Karen Gelmon
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Karen Gelmon
Login to view comments.
Click here to Login
Videos